During the past decade, NSW Breast Cancer Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NSW Breast Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Lymphoma Trials Office" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "Nordic Lymphoma Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "NSW Breast Cancer Institute" are "Lung Cancer" (2 trials), "Malignant Melanoma" (2 trials), "Head and Neck Cancer" (1 trials), "Leukemia" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "NSW Breast Cancer Institute" in a lesser frequency.

Most popular intervention types in "NSW Breast Cancer Institute" are "Biological" (6 trials), "Drug" (4 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "CancerVax vaccine (CANVAXIN)" (2 trials), "BCG vaccine" (1 trials), "CHOP regimen" (1 trials), "adjuvant therapy" (1 trials) and "aldesleukin" (1 trials). Other intervention names were less common.

The vast majority of trials in "NSW Breast Cancer Institute" are 7 trials for "All" genders.

Currently, there are NaN active trials in "NSW Breast Cancer Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in NSW Breast Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NSW Breast Cancer Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".